A 31-year-old woman, gravida 0, presents to the clinic for evaluation of a 14-month histor… — USMLE Step 2 CK

A $31$ -year-old woman, gravida $0$ , presents to the clinic for evaluation of a $14$ -month history of inability to conceive. The patient and her partner have been engaging in regular, unprotected intercourse. Menarche occurred at age $12$ . Her menses were previously regular, occurring every $28$ days, but over the past year, they have become irregular, occurring every $45$ to $60$ days. The patient has also noticed new, coarse dark hairs on her chin and upper lip. She reports feeling unusually fatigued recently, which she attributes to stress at her job, and has gained $6 \text{ kg}$ ( $13.2 \text{ lbs}$ ) over the past $6$ months despite no changes in her diet.

Vital signs show a temperature of $36.6^\circ\text{C}$ ( $97.9^\circ\text{F}$ ), blood pressure of $112/74 \text{ mmHg}$ , and heart rate of $58\text{/min}$ . Her body mass index (BMI) is $32 \text{ kg/m}^2$ . Physical examination reveals coarse facial hair and dry skin. Pelvic examination is unremarkable.

Laboratory evaluation reveals the following:

Follicle-stimulating hormone (FSH): $5 \text{ mIU/mL}$
Luteinizing hormone (LH): $6 \text{ mIU/mL}$
Prolactin: $48 \text{ ng/mL}$ (Normal: $<20 \text{ ng/mL}$ )
Thyroid-stimulating hormone (TSH): $14.5 \text{ \mu IU/mL}$ (Normal: $0.4-4.0 \text{ \mu IU/mL}$ )
Free thyroxine (T4): $0.6 \text{ ng/dL}$ (Normal: $0.8-1.8 \text{ ng/dL}$ )

A urine pregnancy test is negative.

Which of the following is the most appropriate initial management for this patient's inability to conceive?

LevothyroxineAnswer
B
Letrozole
C
Cabergoline
D
Magnetic resonance imaging of the brain
E
Measurement of early morning 17-hydroxyprogesterone

Answer

Levothyroxine

This patient's infertility, oligomenorrhea, and hirsutism are all downstream effects of untreated primary hypothyroidism. In primary hypothyroidism, decreased negative feedback from low thyroxine (T4) levels leads to increased secretion of thyrotropin-releasing hormone (TRH) from the hypothalamus. TRH serves as a potent stimulator of both thyrotrophs (causing the elevated TSH) and lactotrophs in the anterior pituitary. This lactotroph stimulation results in secondary hyperprolactinemia. Elevated prolactin then disrupts the pulsatile release of gonadotropin-releasing hormone (GnRH), resulting in ovulatory dysfunction and infertility. Furthermore, low levels of circulating thyroid hormone decrease the hepatic synthesis of sex hormone-binding globulin (SHBG). Lower SHBG leads to a higher fraction of free (biologically active) testosterone, which manifests clinically as hirsutism. Treating the root cause with levothyroxine will normalize TRH secretion, subsequently normalizing prolactin levels, restoring regular ovulatory cycles, and increasing SHBG production to improve hyperandrogenic symptoms.

Step-by-Step Solution

Analyze the clinical presentation and laboratory values.

The patient presents with oligomenorrhea, infertility, hirsutism, weight gain, fatigue, and bradycardia. Labs show high TSH and low free T4 (primary hypothyroidism), alongside mildly elevated prolactin.

Identifying all abnormal findings ensures the underlying pathophysiology is correctly recognized rather than prematurely diagnosing based on isolated symptoms.

Connect the endocrine axes to explain the constellation of symptoms.

Primary hypothyroidism results in low T4, which decreases negative feedback on the hypothalamus, leading to increased thyrotropin-releasing hormone (TRH) secretion. TRH directly stimulates both thyrotrophs (increasing TSH) and lactotrophs (increasing prolactin).

Understanding that TRH stimulates prolactin release is key to recognizing that the hyperprolactinemia is secondary to the thyroid dysfunction.

Determine the mechanism for infertility and hyperandrogenism.

Elevated prolactin inhibits the pulsatile release of GnRH, leading to ovulatory dysfunction and infertility. Additionally, low thyroid hormone levels decrease hepatic synthesis of sex hormone-binding globulin (SHBG), increasing free testosterone and causing hirsutism.

This dual mechanism explains why primary hypothyroidism acts as a profound mimic of polycystic ovary syndrome (PCOS).

Select the most appropriate initial management based on the root cause.

Exogenous levothyroxine administration.

Restoring a euthyroid state will suppress TRH, normalizing prolactin levels, restoring ovulatory cycles, and increasing SHBG to resolve the hyperandrogenism.

Key Concept

Primary hypothyroidism as a systemic cause of secondary hyperprolactinemia, ovulatory dysfunction, and hyperandrogenism (due to decreased SHBG).

Estimated Time:1m 30s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic